Journal of Leukemia
Open Access

Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, D-48149 Muenster, Germany

Publications

• Review   
  The Impact of Hematologic Malignancies on the Treatment and Prognosis of Acute Coronary Syndrome
  Author(s): Georg Karanatsios* and Stefan Lange
  
  Survival after myocardial infarction has improved but there is still a difference in clinical outcome and mortality. So far, there is very limited information on the effects of patients with an acute coronary syndrome in cancer. Although the survival after a ST-Segment Elevation Myocardial Infarction (STEMI) has improved and data demonstrates mortality 12 months after a STEMI of less than 4 percent, the cancer patients are not included in this clinical data results. As we know, cancer and cardiovascular diseases have a high incidence in elderly days, thus more cancer patients are suffering an Acute Coronary Syndrome (ACS). Patients with cancer have been excluded from most large cardiology studies and registries. Therefore, little is known about the effect of ACS in cancer patients and treatment remains empirical. Even less is known about the influence of hematological tumors on ACS. T.. View More»
  DOI: 10.35248/2329-6917.24.12.367

  Abstract HTML PDF